Equity Research, Broker Reports, and media content on Advanced Oncotherapy

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Advanced Oncotherapy
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Advanced Oncotherapy. We currently have 107 research reports from 5 professional analysts.

Open
26.5p
Range Today
26.5/26.5p
52 Week
21.0/52.0p
Daily Volume
0.0k
# Shares
244.4m
Daily Liquidity
(0%)
Pension Liability
£0m
Enterprise Value
£92.9m
Market Cap
£64.8m
Latest PE (hist)
Div Yield
Date Source Announcement
26Feb20 15:40 EQS Hardman & Co Research: Q&A with Dr Martin Hall on Advanced Oncotherapy (AVO): Confidence in LIGHT gaining momentum
20Feb20 07:00 RNS UHB and AVO to collaborate over LIGHT system
20Feb20 07:00 RNS UHB and AVO to collaborate over LIGHT system
17Feb20 11:45 EQS Hardman & Co Research: Advanced Oncotherapy (AVO): Confidence in LIGHT gaining momentum
17Feb20 07:00 RNS Purchase of a LIGHT proton therapy system
11Feb20 07:00 RNS Partnership with The London Clinic
04Dec19 07:15 EQS Hardman & Co Research: Advanced Oncotherapy (AVO): Proving the accuracy and superiority of minibeams
  • Frequency of research reports

     

  • Research reports on

    Advanced Oncotherapy

  • Providers covering

    Advanced Oncotherapy